RNA (Avidity Corp) Bozor qiymatining balans qiymatiga nisbati

RNA (Avidity Biosciences Inc) - kompaniyaning tovar belgisi

Avidity Biosciences (RNA) kompaniyasining joriy narxlar grafigi ekologik toza laboratoriya chiqindilarini qayta ishlash usullarini joriy etayotgan biofarmatsevtika biznesi dinamikasini aks ettiradi. Avidity Biosciences yuqori darajadagi daromadlilikni saqlab qolish uchun mustahkam infratuzilma va eksklyuziv patentlarga tayanadi, bunda asosiy ko'rsatkich 0.64 miqdorini tashkil etadi. Katta hajmdagi R&D investitsiyalari va FDA ning qat'iy nazorati bozorga yangi ishtirokchilar kirishi uchun yengib bo'lmas to'siqlarni yaratib, emitentning dominant mavqeini mustahkamlaydi.

Avidity Corp (RNA) - Bozor kapitallashuvining balans qiymatiga nisbati 04.07.2022dan 27.10.2026gacha

RNA (Avidity Biosciences Inc): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Avidity Biosciences|RNA - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Avidity|RNA - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Avidity Biosciences|RNA - Balans kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati aviditybiosciences.com|RNA - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Avidity Biosciences|RNA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Avidity|RNA - Kompaniyaning umumiy qarz majburiyatlari|Balans kapitallashuviga qarzlar Avidity
Kompaniyaning dastlabki tahlili:RNA, Avidity Biosciences
Avidity Biosciences Inc ishlab chiqargan mahsulot

Aktivlarni stress-testdan o'tkazish uchun investor biznes uchun to'langan premium miqdorini aniqlash maqsadida kompaniyaning bozor qiymatini uning sof aktivlari bilan solishtirishi muhimdir. Avidity Biosciences (RNA) kompaniyasidagi ishonchli oligonukleotid logistikasi va test nazorati operatsion barqarorlikni ta'minlaydi, bu esa bozor qiymatining kitob kapitaliga nisbati bilan birgalikda, kapitalni boshqarish samaradorligini soha hamkasblari bilan solishtirib baholash imkonini beradi.

Raqobatchilar tahlili

Bozor kapitallashuvining balans qiymatiga nisbati Tempus Labs|QGEN (qiagen.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Ionis (IONS)|Kapitallashuvning balans qiymatiga nisbati Repligen Corp|Bozor kapitallashuvining balans qiymatiga nisbati CRSP|Bozor kapitallashuvining balans qiymatiga nisbati GeneDx Corp (WGS)|Bozor kapitallashuvining balans qiymatiga nisbati RARE (Ultragenyx Pharmaceutical)|BEAM - Bozor kapitallashuvining balans qiymatiga nisbati|SRPT - Kapitallashuvning sof aktivlarga nisbati|TWST - Bozor qiymatining balans qiymatiga nisbati|10x Genomics Corp - Bozor kapitallashuvining balans qiymatiga nisbati|Intellia Corp (NTLA) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati Stoke Therapeutics (STOK)|Kapitallashuvning balans qiymatiga nisbati biolifesolutions.com|WVE (Wave Life Sciences Ltd.) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Maze Therapeutics, Inc. MAZE|Kapitallashuvning sof aktivlarga nisbati Sionna Pharma (SION)|PRME - Bozor kapitallashuvining balans qiymatiga multiplikatori|TSHA (Taysha Gene Therapies) - Kapitallashuvning sof aktivlarga nisbati|uniqure.com (QURE) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati MeiraGTx MGTX|REGENXBIO Inc (RGNX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati Solid Bio|Bozor qiymatining balans qiymatiga nisbati Ocugen Pharma|PACB (Pacific Biosciences) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi BNTC (benitec.com)|DSGN: Bozor qiymatining balans qiymatiga nisbati|Rocket Pharma - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati FDMT (4D Molecular Therapeutics Inc)|LXEO - Balans qiymatiga nisbatan bozor kapitallashuvi|KRRO (korrobio.com) - Bozor kapitallashuvining balans qiymatiga nisbati|editasmedicine.com (EDIT) - Kapitallashuvning sof aktivlarga nisbati|SLN: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi ProQR Therapeutics NV|Codexis, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti SGMO (Sangamo BioSciences)|NAUT - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati metagenomi.co MGX|DTIL: Bozor kapitallashuvining balans qiymatiga nisbati|GBIO - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati BOLD|XCUR (Exicure) - Bozor qiymatining balans qiymatiga koeffitsiyenti|IMNN: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi PHIO|Mustang Bio, Inc. (MBIO) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati RNAZ (transcodetherapeutics.com)|BNGO - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Applied DNA Corp APDN|bluebird bio, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|IPA - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Omega Therapeutics, Inc.|OMIC (Singular Genomics Systems, Inc.) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Regulus Therapeutics Inc (RGLS)|Kapitallashuvning balans qiymatiga nisbati Syros Pharmaceuticals, Inc|Bozor kapitallashuvining balans qiymatiga nisbati TBIO|Bozor kapitallashuvining balans qiymatiga nisbati traconpharma.com (TCON)|Bozor kapitallashuvining balans qiymatiga nisbati UBX (Unity Biotechnology, Inc.)